Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | PPARG | P37231 | 3/20 | 0.42 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.42 |
| ▸ | RXRA | P19793 | 2/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | CNR1 | P21554 | 6/20 | 0.38 |
| ▸ | CNR2 | P34972 | 4/20 | 0.38 |
| ▸ | F7 | P08709 | 3/20 | 0.37 |
| ▸ | F3 | P13726 | 3/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | PPARD | Q03181 | 2/20 | 0.37 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9905939 | 0.93 | ALDH1A1 (0.44) | ALDH1A1CYP19A1MAPTPPARGOXER1 | |
| SCHEMBL9905959 | 0.90 | ALDH1A1 (0.47) | ALDH1A1CYP19A1MAPTPPARGOXER1 | |
| SCHEMBL9905954 | 0.89 | MEN1 (0.44) | ALDH1A1CYP19A1MAPTPPARGFFAR1 | |
| SCHEMBL9905969 | 0.80 | NR1I2 (0.44) | ALDH1A1CYP19A1MAPTPPARGOXER1 | |
| SCHEMBL9905958 | 0.76 | ADORA3 (0.54) | ALDH1A1CYP19A1PPARGOXER1RXRA | |
| SCHEMBL9905971 | 0.74 | ALDH1A1 (0.56) | ALDH1A1ADORA3NR1I2PTGS2CYP3A4 | |
| SCHEMBL353829 | 0.73 | ALDH1A1 (0.72) | ALDH1A1CYP19A1MAPTPPARGOXER1 | |
| SCHEMBL353830 | 0.73 | ALDH1A1 (0.72) | ALDH1A1CYP19A1MAPTPPARGOXER1 | |
| SCHEMBL16472576 | 0.67 | ALDH1A1 (0.67) | ALDH1A1CYP19A1MAPTPPARGOXER1 | |
| SCHEMBL15678968 | 0.67 | ALDH1A1 (0.67) | ALDH1A1CYP19A1MAPTPPARGOXER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9925165-B2 | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof | SCF PHARMA INC. (CA) | 2018-03-27 | — | — | US | disclosed |
| US-20170014369-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2017-01-19 | — | — | US | disclosed |
| US-9480660-B2 | Methods for treating inflammatory diseases with compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof | SCF PHARMA INC. (CA) | 2016-11-01 | — | — | US | disclosed |
| US-9233915-B2 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof | SCF PHARMA INC. (CA) | 2016-01-12 | — | — | US | disclosed |
| US-9101563-B2 | Method for treating an inflammatory disease with compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof | SCF PHARMA INC (CA) | 2015-08-11 | — | — | US | disclosed |
| US-20150057348-A1 | METHODS FOR TREATING INFLAMMATORY DISEASES WITH COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2015-02-26 | — | — | US | disclosed |
| US-20140296344-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2014-10-02 | — | — | US | disclosed |
| US-8816110-B2 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof | SCF PHARMA INC. (CA) | 2014-08-26 | — | — | US | disclosed |
| US-8722737-B2 | Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof | SCF PHARMA INC. (CA) | 2014-05-13 | — | — | US | disclosed |
| US-20130059911-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2013-03-07 | — | — | US | disclosed |
| US-20120213872-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2012-08-23 | — | — | US | disclosed |
| US-20120213823-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2012-08-23 | — | — | US | disclosed |
| US-20120208884-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2012-08-16 | — | — | US | disclosed |
| US-8222295-B2 | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2012-07-17 | — | — | US | disclosed |
| US-8198324-B2 | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2012-06-12 | — | — | US | disclosed |
| US-8119690-B2 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2012-02-21 | — | — | US | disclosed |
| US-20100196496-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2010-08-05 | — | — | US | disclosed |
| US-20100160261-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | SCF PHARMA INC. (CA) | 2010-06-24 | — | — | US | disclosed |
| US-20090292019-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | SCF PHARMA INC. (CA) | 2009-11-26 | — | — | US | disclosed |
| US-20090291102-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2009-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120213872-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF | MGLL, PNLIP, FASN | ALDH1A1 1011/4885CYP19A1 1258/4885MAPT 4476/4885 |
| US-20130059911-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | FASN, MGLL, FADS1 | ALDH1A1 695/4885CYP19A1 1551/4885MAPT 4799/4885 |
| US-20100196496-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | MGLL, PNLIP, FASN | ALDH1A1 1033/4885CYP19A1 1240/4885MAPT 4426/4885 |
| US-20120208884-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF | MGLL, PNLIP, FASN | ALDH1A1 1011/4885CYP19A1 1258/4885MAPT 4476/4885 |
| US-20150057348-A1 | METHODS FOR TREATING INFLAMMATORY DISEASES WITH COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF | PPARG, PTGES, PTGIS | ALDH1A1 1362/4885CYP19A1 3202/4885MAPT 3620/4885 |
| US-20090292019-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | FASN, MGLL, FADS1 | ALDH1A1 695/4885CYP19A1 1551/4885MAPT 4799/4885 |
| US-20170014369-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | PPARG, PTGES, PTGIS | ALDH1A1 1476/4885CYP19A1 3274/4885MAPT 3746/4885 |
| US-20140296344-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | FASN, MGLL, FADS1 | ALDH1A1 695/4885CYP19A1 1551/4885MAPT 4799/4885 |
| US-20090291102-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | MGLL, PNLIP, FASN | ALDH1A1 1033/4885CYP19A1 1240/4885MAPT 4426/4885 |
| US-20120213823-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF | MGLL, PNLIP, FASN | ALDH1A1 1011/4885CYP19A1 1258/4885MAPT 4476/4885 |
| US-20100160261-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | FASN, MGLL, FADS1 | ALDH1A1 695/4885CYP19A1 1551/4885MAPT 4799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.